Concepedia
Statistics
Publications
15
Citations
463
H-Index
13
Active since
2018
Affiliations
Peter MacCallum Cancer Centre(Current)
The University of Melbourne
St Vincent's Hospital Melbourne
APR Technologies (Sweden)
Victorian Clinical Genetics Services
Kenji M. Fujihara is an author at Peter MacCallum Cancer Centre specializing in medicine, cell biology, and tumor biology.
Top concepts
MedicineOncologyPathologyCell BiologyTumor BiologyCancer ResearchApoptosisCell CycleCell DeathImmunology
Publications per year
2018–2023
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction
Kenji M. Fujihara, Bonnie Z. Zhang, Thomas D. Jackson et al. · Science Advances · 2022 · 79 citations · Full text
Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjærg syndrome
Yilin Kang, Alexander J. Anderson, Thomas D. Jackson et al. · eLife · 2019 · 50 citations · Full text
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation Status
Kenji M. Fujihara, Mariana Corrales Benitez, Carlos S. Cabalag et al. · Molecular Cancer Therapeutics · 2021 · 44 citations · Full text
A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
Sophia Ceder, Sofi Eriksson, Emarndeena H. Cheteh et al. · EMBO Molecular Medicine · 2020 · 42 citations · Full text
The TIM22 complex mediates the import of sideroflexins and is required for efficient mitochondrial one-carbon metabolism
Thomas D. Jackson, Daniella H. Hock, Kenji M. Fujihara et al. · Molecular Biology of the Cell · 2021 · 35 citations · Full text
1–5 of 15